Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion type Assertion NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_head.
- NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion description "[CTC amount reflects the aggressiveness of tumors, therefore their detection can be used to determine the prognosis and treatment of cancer patients.The aim of this study was to evaluate human chorionic gonadotropin beta subunit (CGB) and gonadoliberin type 1 (GNRH1) expression as markers of tumor cells circulating in peripheral blood of gynecological cancer patients, indicating the metastatic spread of tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_provenance.
- NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion evidence source_evidence_literature NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_provenance.
- NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion SIO_000772 21827674 NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_provenance.
- NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion wasDerivedFrom befree-20140225 NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_provenance.
- NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_assertion wasGeneratedBy ECO_0000203 NP402013.RA18IrPO81C61Jot5al_jYipf3gxTZUvJzYFM503Cpd7E130_provenance.